Folate levels in hepatocellular carcinoma patients with portal vein thrombosis

BMC Gastroenterology

Table 2 Characteristics of the patients and risk factors

	With PVT = 78 pt		NPVT = 60 pt		Controls = 70 pt		PVT versus NPVT			PVT versus control			NPVT versus control
	N	%	N	%	N	%	p	95% CI O.R.	Sig	p	95% CI O.R.	Sig	p	95% CI O.R.	Sign
Smokers/no smokers	28	35.90	27	45.00	20	28.57	0.2975	0.3451 to 1.347	ns	0.3821	0.7087 to 2.877	ns	0.0672	0.9742 to 4.156	ns
Diabetes mell	10	12.82	9	15.00	8	11.43	0.8049	0.3208 to 2.078	ns	> 0.9999	0.4387 to 3.093	ns	0.6078	0.5114 to 3.884	ns
Hypertension	12	15.38	14	23.33	10	14.29	0.2757	0.2682 to 1.431	ns	> 0.9999	0.4575 to 2.783	ns	0.2569	0.7175 to 4.602	ns
Renal failure	10	12.82	12	20.00	12	17.14	0.3484	0.2274 to 1.425	ns	0.4952	0.2786 to 1.697	ns	0.8211	0.5195 to 2.809	ns
Cardiovascular dis	18	23.08	16	26.67	10	14.29	0.6921	0.3726 to 1.791	ns	0.2096	0.8020 to 4.219	ns	0.1226	0.9064 to 5.360	ns
Dyspepsia	15	19.23	21	35.00	12	17.14	0.0501	0.2122 to 0.9495	ns	0.8325	0.5049 to 2.610	ns	0.026	1.132 to 5.798	*
Alcohol	10	12.82	16	26.67	0	0	0.0489	0.1659 to 0.9651	*	0.0016	–	**	< 0.0001	–	****
HCV	35	44.87	25	41.67	0	0	0.732	0.5902 to 2.235	ns	< 0.0001	–	****	< 0.0001	–	****
HBV	25	32.05	9	15.00	0	0	0.028	1.135 to 6.349	*	< 0.0001	–	****	0.0007	–	***
HCC unknown aetiology	8	10.26	10	16.67	0	0	0.3132	0.2084 to 1.480	ns	0.007	–	**	0.0003	–	***

Fisher's exact test, 95% CI Odds Ratio (O.R.) Baptista–Pike method
pt, patients; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; HBV, hepatitis B virus
Summary: *< 0.05; **< 0.005; ***< 0.001; ****< 0.0001

ISSN: 1471-230X